ERAP2 Activators are a diverse group of chemical compounds that indirectly enhance the functional activity of ERAP2, a key enzyme in the antigen presentation pathway. These activators work primarily by modulating the enzyme's interaction with peptide substrates or altering the pool of peptides available for ERAP2-mediated trimming. Amino acids like L-Lysine play a critical role, serving as substrates that directly engage with ERAP2, thereby influencing its enzymatic activity.
Furthermore, compounds like Phosphoramidon and MG-132, which are inhibitors of metalloproteases and proteasomes respectively, contribute to ERAP2 activation by affecting the peptide pool. This modulation is crucial for the enzyme's role in generating peptides that fit MHC class I molecules for immune recognition. Additionally, Z-L-Leucine, by interacting with ERAP2, influences the enzyme's peptide trimming dynamics. Similarly, antibiotics such as Bacitracin and protease inhibitors like Aprotinin, Leupeptin, and E-64 indirectly enhance ERAP2 activity by influencing the overall protease balance and the intracellular peptide environment.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Lysine | 56-87-1 | sc-207804 sc-207804A sc-207804B | 25 g 100 g 1 kg | $93.00 $258.00 $519.00 | ||
Amino acid that enhances ERAP2's enzymatic activity by serving as a substrate, thereby influencing peptide trimming in antigen presentation. | ||||||
Phosphoramidon | 119942-99-3 | sc-201283 sc-201283A | 5 mg 25 mg | $195.00 $620.00 | 8 | |
Metalloprotease inhibitor; indirectly influences ERAP2 activity by affecting the peptide pool available for trimming. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor; can increase ERAP2 activity by altering the pool of peptides for ERAP2-mediated processing. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Selective proteasome inhibitor; potentially enhances ERAP2 function by modulating antigenic peptide generation. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $110.00 $400.00 $1615.00 | 51 | |
Protease inhibitor; indirectly enhances ERAP2 activity by influencing overall protease balance, affecting ERAP2 substrates. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $61.00 | ||
Leucine analog; modulates ERAP2 activity by competing with natural substrates, influencing peptide trimming dynamics. | ||||||
Bacitracin | 1405-87-4 | sc-252399 | 5 g | $87.00 | 1 | |
Peptide antibiotic; can indirectly modulate ERAP2 activity by affecting peptide availability through inhibition of other peptidases. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $72.00 $145.00 $265.00 $489.00 $1399.00 $99.00 | 19 | |
Serine/cysteine protease inhibitor; influences ERAP2 activity by modulating the intracellular peptide environment. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $275.00 $928.00 $1543.00 | 14 | |
Cysteine protease inhibitor; indirectly enhances ERAP2 activity by affecting the pool of peptides available for ERAP2 processing. | ||||||